CN
Mobile Site
Search
Sunshine and health are two important elements in a high-quality life. Linuo Group, Wspecializing in ith solar power and healthcare branches industriesas its two development priorities, Linuo Group has been striving to develop itself steadily and to build a life of high quality for all peopleus all.
We will bring you the latest news. We may be separated by oceans and landmasses, but we share the fate of our planet. What happens in China, even in one corporation like Linuo Group, is relevant to all of us in one global marketplace and in one natural environment.
Linuo Group is a meeting of subsidiaries in several fast-growing sectors, but more importantly, is an integration of several historic companies, some a century old, with newly established high tech companies. This is probably a unique combination in China, inspiring all Linuo team members with tradition and innovation, while creating a special and respected brand.
Constant innovation is a key driver of corporate growth. Linuo Group places great emphasis on innovation in all areas of production, service, management and marketing. We are here to meet the needs of consumers in the new era and ceaseless innovation is crucial.
Linuo Group companies have taken quite different paths to lead them to the present day. Some are more than a century old, not something that can be said about many Chinese enterprises today, while others are newly founded high-tech companies. This makes for an interesting and mutually inspiring mix of Group members, contributing to a deep and meaningful Linuo brand.
· Do you want to design a better future?
· Then Linuo Group is for you!
Keyuan Pharma, a company under Linuo Group, announces its successful initial public offering (IPO) on the Innovative Enterprise Board of Shenzhen Stock Exchange. The company's shares began trading under the ticker symbol 301281 on April 4, 2023.
The company has been focusing on the R&D and manufacturing of chemical APIs since its establishment in 2004 and is now expanding its business to chemical preparations based on its products. After nearly 20 years of development, Keyuan Pharma has reached a strong production capacity. Supported by modern synthesis facilities, mature synthesis routes and GMP-compliant QC standards, it can now reach higher reaction yield and product purity with lower wastes and emissions.
The funds raised shall be mainly invested in technology transformation of an integrated API production line, an eco-friendly flexible API production line, construction of a research institute and drug R&D projects.